Emil Gaysin

Emil stands out as a professional in managing the needs of the biomedical, biotech and pharmaceutical industries. His training includes a Master’s degree in Biomedical Business Management from the Universitat Internacional de Catalunya and a specialised programme in Market Access organised by Biocat. He has a scientific background acquired during his degree in Biology at the University of Barcelona, a specialisation in Molecular, Cellular, and Systems Biology, and experience in rare diseases. Emil combines technical knowledge with a strategic vision. In his professional career, he has analysed more than 15 innovative technologies. He has experience in the creation of Joint Ventures, as well as the development and implementation of strategic and business plans.